The innovative evolution of cancer gene and cellular therapies

被引：0

作者：

P Lam

G Khan

R Stripecke

K M Hui

N Kasahara

K-W Peng

B-A Guinn

机构：

[1] National Cancer Centre,Division of Cellular and Molecular Research

[2] University of Bedfordshire,Department of Life Sciences

[3] Lymphatic Cell Therapy Program,Department of Biochemistry

[4] Excellence Cluster for Regenerative Biology (REBIRTH),Department of Medicine

[5] Hannover Medical School,Department of Molecular Medicine

[6] Yong Loo Lin School of Medicine,Department of Haematological Medicine

[7] National University of Singapore,undefined

[8] Program in Cancer and Stem Cell Biology,undefined

[9] Duke-NUS Graduate Medicinal School,undefined

[10] David Geffen School of Medicine,undefined

[11] University of California Los Angeles,undefined

[12] Mayo Clinic,undefined

[13] Cancer Sciences Unit,undefined

[14] Somers Cancer Sciences Building,undefined

[15] Southampton University Hospitals,undefined

[16] University of Southampton,undefined

[17] King’s College London School of Medicine,undefined

来源：

Cancer Gene Therapy | 2013年 / 20卷

关键词：

stem cells; immunotherapy; cancer research;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We provide an overview of the latest developments in cancer gene therapy—from the bench to early-stage clinical trials. We describe the most recent work of worldwide teams including experienced scientists and clinicians, reflecting the recent emergence of gene therapy from the ‘Valley of Death’. The treatment efficacy of clinical gene therapy has now been shown in a number of diseases including cancer and we are observing a renewed interest by big pharmaceutical and biotechnology companies most obviously demonstrated by Amgen’s acquisition of Biovex for up to USD$1 billion. There is an opportunity to be cautiously hopeful regarding the future of gene therapy in the clinic and we review here some of the most recent progress in the field.

引用

页码：141 / 149

页数：8

共 50 条

[1] The innovative evolution of cancer gene and cellular therapies
Lam, P.
Khan, G.
Stripecke, R.
Hui, K. M.
Kasahara, N.
Peng, K-W
Guinn, B-A
CANCER GENE THERAPY, 2013, 20 (03) : 141 - 149
[2] The Journal of Cancer Gene and Cellular Therapies
Sobol, R. E.
Scanlon, K. J.
CANCER GENE THERAPY, 2011, 18 (01) : 1 - 1
[3] The Journal of Cancer Gene and Cellular Therapies
R E Sobol
K J Scanlon
Cancer Gene Therapy, 2011, 18 : 1 - 1
[4] (R)Evolution with innovative Combination Therapies
Junker, Annette
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 708 - 708
[5] Application of innovative techniques in genetic and cellular therapies
Endo, Yori
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
[6] CELLULAR THERAPIES IN CANCER
FRIDMAN, WH
MATHIOT, C
TARTOUR, E
DORVAL, T
THIOUNN, N
POUILLART, P
DEBRE, B
BULLETIN DU CANCER, 1995, 82 (03) : 235 - 236
[7] Innovative approaches for cancer therapies
Flanagan, A
GENETIC ENGINEERING NEWS, 2002, 22 (16): : 9 - +
[8] Cellular, gene therapies and Cytokines
Uhlin, M.
Gertow, J.
Okas, M.
Mattsson, J.
BONE MARROW TRANSPLANTATION, 2011, 46 : S310 - S310
[9] Gene and Cellular Therapies for Leukodystrophies
Aerts-Kaya, Fatima
van Til, Niek P.
PHARMACEUTICS, 2023, 15 (11)
[10] Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer
Bautista, Francisco
Verdu-Amoros, Jaime
Geoerger, Birgit
Rubio-San-Simon, Alba
Paoletti, Xavier
Zwaan, C. Michel
Casanova, Michela
Marshall, Lynley V.
Carceller, Fernando
Doz, Francois
Lecinse, Carole
Vassal, Gilles
Pearson, Andrew D. J.
Kearns, Pamela
Moreno, Lucas
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (21) : 2516 - 2526

← 1 2 3 4 5 →